Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02614183
Brief Title: Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study (EVOLVE-1)

First Submitted : November 23, 2015
First Submitted that Met QC Criteria : November 23, 2015
First Posted : November 25, 2015 (Estimate)

Results First Submitted : October 8, 2018
Results First Submitted that Met QC Criteria : November 20, 2018
Results First Posted : November 29, 2018

Certification/Extension First Submitted : March 15, 2018
Certification/Extension First Submitted that Met QC Criteria : March 15, 2018
Certification/Extension First Posted : March 19, 2018

Last Update Submitted that Met QC Criteria : June 10, 2020
Last Update Posted : June 17, 2020